Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery

Hypertension in Pregnancy

Volumn 30, Issue 3, 2011, Pages 347-358

  Xiong, Yu ^a   Zhou, Shu Feng ^b   Zhou, Rong ^c   Yang, Dan ^a   Xu, Zheng Fang ^a   Lou, Yi Ting ^a   Guo, Qing Sang ^a   Hu, Rong ^a   Peng, Ting ^a   Ma, Duan ^a   Li, Xiao Tian ^a  

^a FUDAN UNIVERSITY   (China)

^b RMIT UNIVERSITY   (Australia)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Coagulation; Fibrinolysis; Preeclampsia; Thrombophilia; Tissue factor

Indexed keywords

PADGEM PROTEIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; DELIVERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOSTASIS; HUMAN; PREECLAMPSIA; PREGNANCY; PROTEINURIA; UMBILICAL CORD BLOOD;

ADULT; DELIVERY, OBSTETRIC; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; P-SELECTIN; PRE-ECLAMPSIA; PREGNANCY; THROMBOMODULIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UMBILICAL CORD; VON WILLEBRAND FACTOR;

EID: 79959925021     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950903572274     Document Type: Article

References (33)

1. Roberts JM, Cooper DW, Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357:53-56. (Pubitemid 32056505)
2. Gilbert JS, Ryan MJ, Lamarca BB, et al. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 2008; 294:H541-H550. (Pubitemid 351253261)
3. Xia Y, Ramin SM, Kellems RE. Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 2007; 50:269-275. (Pubitemid 47205769)
4. Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005; 106:517-524. (Pubitemid 41208783)
5. Schjetlein R, Haugen G, Wisloff F. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet Gynecol Scand 1997; 76:541-546. (Pubitemid 27279606)
6. Holthe MR, Staff AC, Berge LN, et al. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women. Am J Obstet Gynecol 2004; 190:1128-1134. (Pubitemid 38561536)
7. Oron G, Ben-Haroush A, Hod M, et al. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia. Obstet Gynecol 2006; 107:896-900.
8. Teng YC, Lin QD, Lin JH, et al. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J Perinat Med 2009; 37:343-348.
9. Manco-Johnson MJ. Development of hemostasis in the fetus. Thromb Res 2005; 115(Suppl 1):55-63.
10. Hyytiainen S, Wartiovaara-Kautto U, Ulander VM, et al. The procoagulant effects of factor V Leiden may be balanced against decreased levels of factor V and do not reflect in vivo thrombin formation in newborns. Thromb Haemost 2006; 95:434-440.
11. Edstrom CS, Calhoun DA, Christensen RD, Expression of tissue factor pathway inhibitor in human fetal and placental tissues. Early Hum Dev 2000; 59:77-84.
12. Tay SP, Cheong SK, Boo NY, Circulating tissue factor, tissue factor pathway inhibitor and D-dimer in umbilical cord blood of normal term neonates and adult plasma. Blood Coagul Fibrinolysis 2003; 14:125-129.
13. Zanardo V, Savio V, Sabrina G, et al. The effect of pre-eclampsia on the levels of coagulation and fibrinolysis factors in umbilical cord blood of newborns. Blood Coagul Fibrinolysis 2005; 16:177-181. (Pubitemid 40547271)
14. Zhang B. the application card of neonatal birthweight in different gestation age from fifteen cities of china. Chin J Pediatrics 1989; 27:318.
15. Mello G, Parretti E, Marozio L, et al. Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study. Hypertension 2005; 46:1270-1274. (Pubitemid 43189722)
16. Yin KH, Koh SC, Malcus P, et al. Preeclampsia: haemostatic status and the short-term effects of methyldopa and isradipine therapy. J Obstet Gynaecol Res 1998; 24:231-238. (Pubitemid 28375686)
17. Mackman N, Tilley RE, Key NS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler Thromb Vasc Biol 2007; 27:1687-1693. (Pubitemid 47207163)
18. Steffel J, Luscher TF, Tanner FC. Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications. Circulation 2006; 113:722-731.
19. Lopez-Ramirez Y, Carvajal Z, Arocha-Pinango CL. [Hemostatic system parameters of placental extracts in normal pregnancy and severe preeclampsia]. Invest Clin 2006; 47:233-240. (Pubitemid 44580244)
20. Bellart J, Gilabert R, Angles A, et al. Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol 1999; 106:594-597. (Pubitemid 29245593)
21. Estelles A, Gilabert J, Grancha S, et al. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost 1998; 79:500-508. (Pubitemid 28120779)
22. Dechend R, Homuth V, Wallukat G, et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation 2000; 101:2382-2387. (Pubitemid 30329128)
23. Lockwood CJ, Krikun G, Caze R, et al. Decidual cell-expressed tissue factor in human pregnancy and its involvement in hemostasis and preeclampsia-related angiogenesis. Ann N Y Acad Sci 2008; 1127:67-72. (Pubitemid 351563106)
24. Atamer Y, Kocyigit Y, Yokus B, et al. Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 119:60-66. (Pubitemid 40289099)
25. Cvirn G, Gruber HJ, Koestenberger M, et al. High availability of intravascular tissue factor in neonates. J Pediatr Hematol Oncol 2007; 29:279-283. (Pubitemid 46707503)
26. Nelson KB, Thrombophilias, perinatal stroke, and cerebral palsy. Clin Obstet Gynecol 2006; 49:875-884. (Pubitemid 44691210)
27. Tanjung MT, Siddik HD, Hariman H, et al. Coagulation and fibrinolysis in preeclampsia and neonates. Clin Appl Thromb Hemost 2005; 11:467-473. (Pubitemid 41546775)
28. Franchi F, Cetin I, Todros T, et al. Intrauterine growth restriction and genetic predisposition to thrombophilia. Haematologica 2004; 89:444-449. (Pubitemid 38798549)
29. Schjetlein R, Abdelnoor M, Haugen G, et al. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand 1999; 78:191-197. (Pubitemid 29110281)
30. Krikun G, Huang ST, Schatz F, et al. Thrombin activation of endometrial endothelial cells: a possible role in intrauterine growth restriction. Thromb Haemost 2007; 97:245-253. (Pubitemid 46592145)
31. Di Paolo S, Volpe P, Grandaliano G, et al. Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J Nephrol 2003; 16:650-657. (Pubitemid 38714248)
32. Lee J, Croen LA, Backstrand KH, et al. Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA 2005; 293:723-729. (Pubitemid 40216042)
33. Wu YW, March WM, Croen LA, et al. Perinatal stroke in children with motor impairment: a population-based study. Pediatrics 2004; 114:612-619. (Pubitemid 41529514)